Medical Consumption and Costs during a One-Year Follow-up of Patients with LUTS Suggestive of BPH in Six European Countries: Report of the TRIUMPH Study
| Autor: | F.F.H. Rutten, Richard Berges, Christopher R. Chapple, Marc A. Koopmanschap, N.J.A. van Exel, Joseph McDonnell |
|---|---|
| Přispěvatelé: | Erasmus School of Health Policy & Management |
| Rok vydání: | 2006 |
| Předmět: |
Male
medicine.medical_specialty Pediatrics Time Factors Cross-sectional study Urology medicine.medical_treatment MEDLINE Prostatic Hyperplasia chemistry.chemical_compound Lower urinary tract symptoms medicine Humans Prospective Studies Prospective cohort study Aged business.industry Urination disorder Middle Aged medicine.disease Urination Disorders Surgery Europe Cross-Sectional Studies chemistry Finasteride Costs and Cost Analysis Observational study business Delivery of Health Care Watchful waiting Follow-Up Studies |
| Zdroj: | European Urology, 49, 92-102. Elsevier |
| ISSN: | 1421-993X 0302-2838 |
| Popis: | Objective To determine the medical consumption and associated treatment costs of patients with LUTS suggestive of BPH. Methods A prospective, cross-sectional, observational survey in six European countries: France, Germany, Italy, Poland, Spain and the United Kingdom, with a one-year follow-up of incident and prevalent patients. Results Treatment costs were estimated for 5,057 patients with a mean age of 66 years and a mean IPSS score at inclusion of 11.5. In 30% of patients watchful waiting was the therapy of choice for the full follow-up period, 57% were prescribed alpha-lockers, 11% finasteride and 10% phytotherapy at any moment during the follow-up (including switches and combination of treatment). Surgery rate was 4.9%. Mean one-year treatment costs were €858 per patient, three quarters of which concerned medication costs. Multivariate regression analysis showed that medication choice, complications and undergoing surgery were associated with higher costs. Conclusions Treatment costs for patients with LUTS suggestive of BPH were moderate and largely consisted of medication costs. Daily practice and associated costs varied considerably across the six countries. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect